P. McKeigue, D. McAllister, S. Hutchinson, C. Robertson, D. Stockton, H. Colhoun
{"title":"在苏格兰(REACT-SCOT)患者中,疫苗对抗严重COVID-19变异(B.1.617.2)的有效性和自第二次接种以来的时间:一项病例对照研究","authors":"P. McKeigue, D. McAllister, S. Hutchinson, C. Robertson, D. Stockton, H. Colhoun","doi":"10.1016/S2213-2600(22)00045-5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"136 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"23","resultStr":"{\"title\":\"Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study\",\"authors\":\"P. McKeigue, D. McAllister, S. Hutchinson, C. Robertson, D. Stockton, H. Colhoun\",\"doi\":\"10.1016/S2213-2600(22)00045-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":326030,\"journal\":{\"name\":\"The Lancet. Respiratory medicine\",\"volume\":\"136 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"23\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet. Respiratory medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/S2213-2600(22)00045-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet. Respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/S2213-2600(22)00045-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study